Tune Therapeutics unveils potentially curative approach to treating chronic HBV infection

Pioneering epigenome editing company Tune Therapeutics has announced it is working on a new and potentially curative approach to treating chronic HBV infection.

Related Keywords

Boston ,Massachusetts ,United States ,Ted Gane ,Derek Jantz ,Lily Ramsey ,University Of Auckland ,Tune Therapeutics ,Image Credit ,Hepatitisb Virus ,American Association ,Liver Diseases ,Chronic ,Gbv ,Herapeutics ,Hepatitis ,Hepatitis B ,Liver ,Medicine ,Virus ,